1 1

Zürich BioGenix

BPC-157 + TB-500 · 10mg/10mg · Pen

BPC-157 + TB-500 · 10mg/10mg · Pen

€199,00 EUR
€199,00 EUR
Распродажа Продано
Налоги включены.
Need a different mg, a blend, or another dose increment? Request a custom pen →

BPC-157 + TB-500 Blend — Pre-Filled Pen

Compound: (Pentadecapeptide + Actin-Sequestering Peptide, 1:1 Blend)
Strength: 5 mg BPC-157 + 5 mg TB-500 = 10 mg total per pen
Chemical Formula: BPC-157 — C₆₂H₉₈N₁₆O₂₂ · TB-500 — C₂₁₂H₃₅₀N₅₆O₇₈S
Molecular Weight: BPC-157 — 1419.53 g/mol · TB-500 — 4963.49 g/mol
Purity: >99% each compound (HPLC verified)
Form: Pre-filled delivery pen (ready-mixed) — no reconstitution required
Storage (unopened): Refrigerate at 2°C – 8°C, protect from light

Quality Control (Certificate of Analysis)
Identification (LC-MS/MS): Confirmed
Purity (HPLC-UV): >99%
Form: Sterile solution — Conforms

Manufactured by: Zürich Biogenix AG, Zurich, Switzerland. Batch-specific Certificate of Analysis provided with each shipment.

For Research Use Only. Not for human or veterinary use. Not a drug, food additive, or cosmetic. Not intended for diagnosis, treatment, cure, or prevention of any disease.

Просмотреть всю информацию
🇨🇭
Swiss Made Zurich since 1998
🔬
HPLC Verified >99% Purity Guaranteed
📋
COA Every Batch Lot-Traceable Compounds
❄️
Cold Chain Maintained End-to-End
🏛️
EU Compliant REACH / Research Use

Research summary

BPC-157 and thymosin beta-4 have each been studied separately in preclinical models of tendon, muscle and tissue repair, and published work on this specific combination is very limited. This summary describes what the literature has investigated. It is not a claim about the effects of our product, which is supplied for laboratory research only.

Mechanism of action

This product is a combination of two research peptides. BPC-157 is a synthetic 15-amino-acid peptide derived from a gastric protein fragment, and published preclinical work has examined its links to angiogenic and nitric oxide signalling. TB-500 is a synthetic peptide based on the actin-binding region of thymosin beta-4, a protein studied for its role in actin regulation and cell migration. Human data for both are limited.

Chemical properties

Two-component blend, 5 mg of each component. Component 1: BPC-157, sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 residues), approx. 1419.5 g/mol. Component 2: TB-500, a synthetic peptide related to thymosin beta-4. Form: pre-filled pen. Purity, identity and content of each component: see the batch Certificate of Analysis.

Storage and handling

Supplied as a pre-filled pen. Store as stated on the product label and Certificate of Analysis, typically cold and protected from light. Avoid freezing and repeated temperature cycling unless the label states otherwise. For laboratory research use only.

Literature references

Selected PubMed records on the two components, scientific background only, not claims about our product. BPC-157: PMID 40005999 (literature and patent review) and PMID 34267654 (review, wound healing). Thymosin beta-4 (related to TB-500): PMID 38994967 (expression in human organs during development, review) and PMID 36709593 (regenerative therapy directions, review). Open any record at https://pubmed.ncbi.nlm.nih.gov/PMID/ . More: https://pubmed.ncbi.nlm.nih.gov/?term=BPC-157

For laboratory research use only. Not for human or veterinary use. Nothing on this page is medical advice.